In the State of Hawaii, there are abundant claims of benefit from cancer patients' use of the fruit juice of Morinda citrifolia (Noni). There is no well documented clinical report in peer review journals. The author here studiously examined 2 such claims through interview, review of the medical records and pathology slides. The author concludes that these cases are valuable experiences and hope to stimulate interest in Noni research as an important part of adjuvant immunotherapy for cancer